my account  log out
 

CAS 142217-69-4 Entecavir

Create: 11/23/2016
Expired Date:11/23/2017
Category: Raw materials [Health&Medical&Pharmaceutical]
Message:Product Name: Entecavir CAS: 142217-69-4 MF: C12H15N5O3 MW: 277.28 Appearance: White To Off-White Powder Entecavir,abbreviated ETV, is an oral antiviral drug used in the treatment of hepatitis B virus (HBV) infection. Entecavir is a reverse transcriptase inhibitor. It prevents the hepatitis B virus from multiplying and reduces the amount of virus in the body. Entecavir is a nucleoside analog(more specifically, a deoxyguanosine analogue) that inhibits reverse transcription, DNA replication and transcription in the viral replication process. Entecavir is mainly used to treat chronic hepatitis B infection in adults and children 2 years and older with active viral replication and evidence of active disease.It is also used to prevent HBV reinfection after liver transplant and to treat HIV patients infected with HBV. Entecavir is weakly active against HIV, however it is not recommended for use in HIV-HBV co-infected patients without a fully suppressive anti-HIV regimen as it may select for resistance to lamivudine and emtricitabine in HIV.
City:Jinan Shandong[CN] 
Location:
 
Dec 21 2016CAS 593-51-1 Methylamine HCL473
Dec 21 2016CAS 83915-83-7 Lisinopril480
Dec 21 2016CAS 141922-90-9 Azasetron HCL468
Dec 21 2016CAS 15307-79-6 Diclofenac Sodium468
Dec 21 2016CAS 104987-11-3 Tacrolimus483
Dec 21 2016CAS 68-96-2 17alpha-Hydroxyprogesterone493
Dec 21 2016CAS 5534-09-8 Beclometasone Dipropionate478
Dec 18 2016SR9011470
Dec 18 2016CAS 118237-47-0 RAD-140496
Dec 18 2016CAS 1202044-20-9 MK-2866468

return back

Copyright © toextrade Inc. All rights reserved. Contact us